Expression of somatostatin receptor in human colorectal cancers and normal mucous tissues

杨小冬,刘福坤,许哲,陈彻,李刚,吴晓宇,张新华,孙桂勤,李宁,黎介寿
DOI: https://doi.org/10.3969/j.issn.1007-810X.2005.01.008
2005-01-01
Abstract:Objectives: The study was designed to determinate whether human colorectal cancers (CRC) would express somatostatin receptor and whether somatostatin could be used in human CRC. Methods: Forty-two specimens of CRC and normal colorectal mucous membrane were taken in patients who suffered CRC. Immunohistochemistry (IHC) technique was used to demonstrate somatostatin receptor expressions. The relationship between expression of SSTR and clinical or pathological factors was analyzed. The expression of SSTR,proliferative index (PI) and apoptosis index (AI) of the CRC were measured. Results: SSTR was expressed in human CRC(35/42, 83.3%) and the normal mucous tissue (39/42, 92.9%, P 0.001 ). Sharply contrasting with SSTR-negative tumors, the normal colorectal mucous membrane was positive. A significant correlation was found between SSTR expression and tumor stage (P0.001) and tumor differentiation (P0.001). And there was no statistically significant relationship between the expression of SSTR and the age, gender of patients and the tumor size (P=0.682, P=0.789, P= 0.342 ). Conclusions: Somatostatin receptor is expressed in human colorectal cancer and appears to be down-regulated compared to the normal mucous tissue. Somatostatin and its analogues can be used in colorectal cancer cases which express somatostatin receptor proteins.
What problem does this paper attempt to address?